PTC Therapeutics Issues Equity Grants to 18 New Hires

The company awarded non-statutory options to purchase 10,050 shares alongside 11,870 restricted stock units. Each stock option carries an exercise price of $74.71, matching the closing market value on the day the Compensation Committee approved the awards. These grants are structured to vest over a four-year period, requiring continued service to reach full maturity. The options feature a 10-year term, with a quarter of the shares vesting after the first year and the remainder distributing in quarterly increments. Meanwhile, the restricted stock units follow a standard annual vesting schedule of 25% per year.